# AbCellera Biologics Inc.: Form SC 13D/A, filed Apr 24, 2023

- Company: [AbCellera Biologics Inc.](/companies/abcl.md) (CIK 1703057)
- Form: SC 13D/A
- Filed: 2023-04-24
- Accepted by EDGAR: Apr 24, 2023, 16:53 ET
- Period: not reported
- Accession: 0001104659-23-049066
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1703057/000110465923049066/tm2313479d1_sc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1703057/000110465923049066/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1703057/000110465923049066/tm2313479d1_sc13da.htm

Filed Apr 24, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-049066. Last ingested by Listed: Nov 15, 2026, 01:06 ET. No prices; not investment advice.
